Trials (Institut Godinot): Revision history

From Beacon

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

6 December 2025

3 December 2025

2 December 2025

3 December 2023

  • curprev 23:5223:52, 3 December 2023‎ Francine talk contribs‎ 243,725 bytes +243,725‎ Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut Godinot page '''NCTID''': NCT03943667 '''Title''': Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma '''Study Summary''': This study aims to evaluate whether the combination of gemcitabine and paclitaxel allows to improve the overall survival compared to gemcitabine alone, in patients with metastatic Pancreatic Ductal Aden..."